Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A33119835" target="_blank" >RIV/61989592:15110/08:33119835 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Multiple myeloma: scintigraphy using technetium-99m-2-methoxyisobutylisonitrile
Original language description
Multiple myeloma (MM) is a clonal B-lymphocyte neoplasm of plasma cells. It accounts for 1% of all malignant diseases and represents 10% of hematologic malignancies. The hallmark of MM is the presence of a monoclonal protein (MIG), produced by the abnormal plasma cells in the blood or urine. The whole body scintigraphy using Tc-99m-MIBI seems to be an easy, sensitive, and available parameter of biological activity of multiple myeloma (MM). Individual patterns of Tc-99m-MIBI uptake in MM patients showeda close association with the grade of disease activity, correlation with clinical stage of the disease and allowed with high sensitivity the discrimination of the patients in remission from those with recurrent disease. Patients with MGUS had mostly physiological pattern of Tc-99m-MIBI uptake, or only a very low activity of diffuse pattern.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)